Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

A $10.3 million grant from the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, will fund ...

SemiAnalysis debunks the $6 million DeepSeek AI training cost myth, revealing a massive $1.3 billion investment in ...

Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance last spring.

January 31, 2025 expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for severe sickle cell disease . Scientists comment on final draft guidance fro ...

Compare premiums, out-of-pocket costs and other factors when looking ... A low complaint level to state insurance departments can signify high customer satisfaction. It also offers some of the ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Justin Barbosa, GM and Vice President of TriLink Discovery, added “By integrating Molecular Assemblies technology into ...